Notice2022-04812

Notice of Award of a Single-Source Cooperative Agreement To Fund Southern Nations, Nationalities, and Peoples Regional Health Bureaus, Ethiopia

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 8, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $6,000,000 for Year 1 of funding to the Southern Nations, Nationalities, and Peoples Regional Health Bureaus (SNNPRHB). The award will ensure continuity of quality comprehensive HIV/AIDS prevention, care, and treatment services for controlling the HIV epidemic in SNNPR in Ethiopia. Funding amounts for years 2-5 will be set at continuation.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 45 (Tuesday, March 8, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Page 12963]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04812]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
Southern Nations, Nationalities, and Peoples Regional Health Bureaus, 
Ethiopia

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $6,000,000 for Year 1 of funding to the Southern 
Nations, Nationalities, and Peoples Regional Health Bureaus (SNNPRHB). 
The award will ensure continuity of quality comprehensive HIV/AIDS 
prevention, care, and treatment services for controlling the HIV 
epidemic in SNNPR in Ethiopia. Funding amounts for years 2-5 will be 
set at continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Tesfaye Desta, Center for Global 
Health, Centers for Disease Control and Prevention, US Embassy-Addis 
Ababa, Entoto Road, Addis Ababa, Ethiopia, Telephone: 800-232-6348, 
Email: <a href="/cdn-cgi/l/email-protection#5d353027691d3e393e733a322b"><span class="__cf_email__" data-cfemail="432b2e3977032027206d242c35">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: The single-source award will implement 
activities and provide support regarding prevention, testing and 
counselling, prevention of mother to child transmission, care and 
treatment, laboratory, Strategic Information (M&E, Surveillance, HIS), 
TB/HIV and other public health needs affecting HIV/AIDS programming 
like COVID-19 in the Southern Nations, Nationalities, and Peoples 
Region.
    The award will support the strengthening of public health response 
and programs, including but not limited to HIV/AIDS, in the SNNPR. 
SNNPRHB is in a unique position to conduct this work as it is the only 
government entity with a legal authority (proclamation number 180//
2019) and mandate to plan, manage, administer, and coordinate all 
health-related activities in the region.

Summary of the Award

    Recipient: Southern Nations, Nationalities, and Peoples Regional 
Health Bureaus (SNNPRHB).
    Purpose of the Award: The purpose of this award is to ensure 
continuity of quality comprehensive HIV/AIDS prevention, care, and 
treatment services for controlling the HIV epidemic in SNNPR in 
Ethiopia. This NOFO will help the region close gaps to achieve the 95-
95-95 goals (95% of HIV-positive individuals knowing their status, 95% 
of those receiving antiretroviral therapy [ART], and 95% of those 
achieving viral suppression) and reach HIV epidemic control.
    Amount of Award: The approximate year 1 funding amount will be 
$6,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: March 2, 2022.
Terrance W. Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-04812 Filed 3-7-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on March 8, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.